La nueva vacuna del herpes zóster reduce en casi un 90% los casos de la enfermedad entre mayores de 80 años

A new vaccine for herpes zóster has shown significant effectiveness in reducing cases of the disease. The vaccine has been found to reduce cases by nearly 90% among individuals over 80 years old. Further information on the vaccine and its impact on herpes zóster cases can be found in the original report from El País, which provides more details on this development.